Letter to the Editor
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
Read
8987
Timeswas read the article
2319
Total PDF
6668
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 60 | 25 | 85 |
| 2024 October | 63 | 24 | 87 |
| 2024 September | 58 | 25 | 83 |
| 2024 August | 68 | 41 | 109 |
| 2024 July | 63 | 34 | 97 |
| 2024 June | 58 | 22 | 80 |
| 2024 May | 55 | 44 | 99 |
| 2024 April | 78 | 32 | 110 |
| 2024 March | 74 | 24 | 98 |
| 2024 February | 53 | 29 | 82 |
| 2024 January | 56 | 29 | 85 |
| 2023 December | 39 | 43 | 82 |
| 2023 November | 64 | 54 | 118 |
| 2023 October | 41 | 37 | 78 |
| 2023 September | 37 | 32 | 69 |
| 2023 August | 47 | 22 | 69 |
| 2023 July | 46 | 28 | 74 |
| 2023 June | 43 | 19 | 62 |
| 2023 May | 70 | 36 | 106 |
| 2023 April | 40 | 20 | 60 |
| 2023 March | 72 | 32 | 104 |
| 2023 February | 64 | 24 | 88 |
| 2023 January | 48 | 31 | 79 |
| 2022 December | 401 | 39 | 440 |
| 2022 November | 78 | 36 | 114 |
| 2022 October | 84 | 41 | 125 |
| 2022 September | 96 | 40 | 136 |
| 2022 August | 64 | 45 | 109 |
| 2022 July | 78 | 56 | 134 |
| 2022 June | 60 | 39 | 99 |
| 2022 May | 81 | 56 | 137 |
| 2022 April | 65 | 43 | 108 |
| 2022 March | 95 | 54 | 149 |
| 2022 February | 72 | 50 | 122 |
| 2022 January | 125 | 59 | 184 |
| 2021 December | 73 | 61 | 134 |
| 2021 November | 87 | 46 | 133 |
| 2021 October | 75 | 68 | 143 |
| 2021 September | 87 | 71 | 158 |
| 2021 August | 100 | 71 | 171 |
| 2021 July | 84 | 47 | 131 |
| 2021 June | 179 | 66 | 245 |
| 2021 May | 278 | 80 | 358 |
| 2021 April | 1404 | 240 | 1644 |
| 2021 March | 767 | 122 | 889 |
| 2021 February | 290 | 68 | 358 |
| 2021 January | 378 | 53 | 431 |
| 2020 December | 145 | 26 | 171 |
| 2020 November | 125 | 35 | 160 |
Show all
